Elizabeth T. Masters
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Elizabeth T. Masters.
Pain Practice | 2016
Caroline Schaefer; Rachael Mann; Elizabeth T. Masters; Joseph C. Cappelleri; Shoshana Daniel; Gergana Zlateva; Heather J. McElroy; Arthi Chandran; Edgar H. Adams; Annlouise R. Assaf; Michael McNett; Philip J. Mease; Stuart G. Silverman; Roland Staud
Little information exists on the comparative patient and economic burden of chronic widespread pain (CWP) and fibromyalgia (FM) in the United States.
Journal of Pain and Palliative Care Pharmacotherapy | 2015
Gary M. Oderda; Joanita Lake; Katja Rüdell; Carl L. Roland; Elizabeth T. Masters
ABSTRACT A 2009 systematic review found that the total cost of prescription opioid abuse in 2001 in the United States was approximately
Pain | 2015
Roy E. Palmer; David Carrell; David Cronkite; Kathleen Saunders; David E. Gross; Elizabeth T. Masters; Sean Donevan; Timothy R. Hylan; Michael Von Kroff
8.6 billion and medical expenses were estimated to be
Pain Practice | 2016
Rachel Halpern; Sonali N. Shah; Joseph C. Cappelleri; Elizabeth T. Masters; Andrew Clair
15,884 for opioid abusers and
Journal of Pain Research | 2015
Elizabeth T. Masters; Jack Mardekian; Birol Emir; Andrew Clair; Max Kuhn; Stuart L. Silverman
1,830 for nonabusers. A search was conducted for English publications on the cost of prescription opioid abuse and misuse from 2009 to 2014. The initial literature search identified 5,412 citations. Title and abstract review selected 59 for further review. The final review process resulted in 16 publications for inclusion that examined cost from the payer perspective. Mean costs to the payer for abusers were
Drug and Alcohol Dependence | 2017
Jody L. Green; Becki Bucher Bartelson; M. Claire Le Lait; Carl L. Roland; Elizabeth T. Masters; Jack Mardekian; J. Elise Bailey; Richard C. Dart
23,000–
Annals of the Rheumatic Diseases | 2015
C. Schaefer; E. Adams; Margarita Udall; Elizabeth T. Masters; R. Mann; S. Daniel; H. McElroy; Joseph C. Cappelleri; Andrew Clair; M. Hopps; Roland Staud; Philip J. Mease; Stuart L. Silverman
25,000 per year and excess costs approximately
Pain and Therapy | 2013
Lesley M. Arnold; Joseph C. Cappelleri; Andrew Clair; Elizabeth T. Masters
15,000 per patient. Three papers were identified that presented societal costs, including direct and indirect costs such as criminal justice costs and costs associated with lost productivity. The strongest evidence suggests that societal cost is in excess of
Journal of Pain Research | 2016
Edgar H. Adams; Heather J. McElroy; Margarita Udall; Elizabeth T. Masters; Rachael Mann; Caroline Schaefer; Joseph C. Cappelleri; Andrew Clair; Markay Hopps; Shoshana Daniel; Philip J. Mease; Stuart L. Silverman; Roland Staud
50 billion per year in the United States. Prescription opioid abuse and misuse is a common and important problem throughout the world that has significant associated societal costs and excess medical costs.
Journal of Pain Research | 2015
Birol Emir; Elizabeth T. Masters; Jack Mardekian; Andrew Clair; Max Kuhn; Stuart L. Silverman
Abstract To estimate the prevalence of problem opioid use, we used natural language processing (NLP) techniques to identify clinical notes containing text indicating problem opioid use from over 8 million electronic health records (EHRs) of 22,142 adult patients receiving chronic opioid therapy (COT) within Group Health clinics from 2006 to 2012. Computer-assisted manual review of NLP-identified clinical notes was then used to identify patients with problem opioid use (overuse, misuse, or abuse) according to the study criteria. These methods identified 9.4% of patients receiving COT as having problem opioid use documented during the study period. An additional 4.1% of COT patients had an International Classification of Disease, version 9 (ICD-9) diagnosis without NLP-identified problem opioid use. Agreement between the NLP methods and ICD-9 coding was moderate (kappa = 0.61). Over one-third of the NLP-positive patients did not have an ICD-9 diagnostic code for opioid abuse or dependence. We used structured EHR data to identify 14 risk indicators for problem opioid use. Forty-seven percent of the COT patients had 3 or more risk indicators. The prevalence of problem opioid use was 9.6% among patients with 3 to 4 risk indicators, 26.6% among those with 5 to 6 risk indicators, and 55.04% among those with 7 or more risk indicators. Higher rates of problem opioid use were observed among young COT patients, patients who sustained opioid use for more than 4 quarters, and patients who received higher opioid doses. Methods used in this study provide a promising approach to efficiently identify clinically recognized problem opioid use documented in EHRs of large patient populations. Computer-assisted manual review of EHR clinical notes found a rate of problem opioid use of 9.4% among 22,142 COT patients over 7 years.